Molecular Genetics of Benign Tumors

REFERENCES

• Nowell P.C., Hungerford D.A. A Minute Chromosome in Human Chronic Granulocytic Leukemia. Science 1960; 132: 1497
   Web of Science ®Google Scholar
• Rabbitts T.H. Chromosomal Translocations in Human Cancer. Nature (London) 1994; 371: 143–149
   Google Scholar
• Rowley J.D. A New Consistant Chromosomal Abnormality in Chronic Myelogenous Leukemia Identified by Quinacrine Fluorescence and Giemsa Staining. Nature 1973; 243: 290–293
   PubMed Web of Science ®Google Scholar
• Zech L., Haglund V., Nilsson K., et al. Characteristic Chromosomal Abnormalities in Biopsies and Lymphoid Cell Lines from Patients with Burkitt and non-Burkitt Lymphomas. Int. J. Cancer 1976; 17: 47–56
   PubMed Web of Science ®Google Scholar
• Bernheim A., Berger R., Lenoir G. Cytogenetic Studies on African Burkitt's Lymphoma Cell Lines; t(8;14), t(2;8) and t(8;22) Translocations. Cancer Genet. Cytogenet. 1981; 3: 307–315
   PubMed Web of Science ®Google Scholar
• Haluska F.G., Tsujimoto Y., Croce C.M. The Molecular Genetics of Non-Hodgkin's Lymphomas. The Non-Hodgkin's Lymphomas, I. Magrath. Williams and Wilkins, Baltimore 1990; 96–108
   Google Scholar
• Rowley J.D. Chromosome Studies in the Non-Hodgkin's Lymphomas: the Role of the 14;18 Translocation. J. Clin. Oncol. 1988; 6: 919–925
   PubMed Web of Science ®Google Scholar
• Ngan B., Chen-Levy Z., Weiss L., et al. Expression in Non-Hodgkin's Lymphomas of the bcl-2 Protein Associated with the t(14;18) Chromosomal Translocation. N. Engl. J. Med. 1988; 318: 1638–1644
   PubMed Web of Science ®Google Scholar
• Nilbert M., Heim S. Uterine Leiomyoma Cytogenetics. Genes Chromosomes Cancer 1990; 2: 3–13
   PubMed Web of Science ®Google Scholar
• Pandis N., Heim S., Willen H., et al. Chromosome Analysis of 96 Uterine Leiomyomas. Cancer Genet. Cytogenet. 1991; 55: 11–18
   PubMed Web of Science ®Google Scholar
• Sreekantaiah C., Leong S.L.P., Karakousis C.P., et al. Cytogenetic Profile of 109 Lipomas. Cancer Res. 1991; 51: 422–433
   PubMed Web of Science ®Google Scholar
• Mandahl N., Höglund M., Mertens F., et al. Cytogenetic Aberrations in 188 Benign and Borderline Adipose Tissue Tumors. Genes Chromosomes Cancer 1994; 9: 207–215
   PubMed Web of Science ®Google Scholar
• Birdsal S.H., Maclennan K.A., Gusterson B.A. t(6;12)(q23;q13) and t(10;16)(q22;p11) in a Phylloides Tumor of the Breast. Cancer Genet. Cytogenet. 1992; 60: 74–77
   PubMed Web of Science ®Google Scholar
• Rohen C., Bonk U., Staats B., et al. Two Human Breast Tumors with Translocations Involving 12q13-15 as the Sole Cytogenetic Abnormality. Cancer Genet. Cytogenet. 1993; 69: 68–71
   PubMed Web of Science ®Google Scholar
• Calabrese G., DiVirgilio C., Cianchetti E., et al. Chromosome Abnormalities in Breast Fibroadenomas. Genes Chromosomes Cancer 1991; 3: 202–204
   PubMed Web of Science ®Google Scholar
• Sandros J., Stenman G., Mark J. Cytogenetic and Molecular Observations in Human and Experimental Salivary Gland Tumors. Cancer Genet. Cytogenet. 1993; 44: 153–167
   Google Scholar
• Bullerdiek J., Wobst G., Meyer-Bolte K., et al. Cytogenetic Subtyping of 220 Salivary Gland Pleomorphic Adenomas: Correlation to Occurrence, Histological Subtype, and In Vitro Cellular Behavior. Cancer Genet. Cytogenet. 1993; 65: 27–31
   PubMed Web of Science ®Google Scholar
• Walter T.A., Xuan Fan A., Medchill M.T., et al. Inv(12)(p11.2q13) in an Endometrial Polyp. Cancer Genet. Cytogenet. 1989; 41: 99–103
   PubMed Web of Science ®Google Scholar
• Vanni R., Dal Cin P., Marras S., et al. Endometrial Polyp: Another Benign Tumor Characterized by 12q13-q15 Changes. Cancer Genet. Cytogenet. 1993; 68: 32–33
   PubMed Web of Science ®Google Scholar
• Mandahl N., Heim S., Arheden K., et al. Chromosomal Rearrangements in Chondromatous Tumors. Cancer 1989; 65: 242–248
   Web of Science ®Google Scholar
• Bridge J.A., Persons D.L., Neff J.R., et al. Clonal Karyotypic Aberrations in Enchondroma. Cancer Detect. Prev. 1992; 16: 215–219
   PubMedGoogle Scholar
• Dal Cin P., Kools P., De Jonge I., et al. Rearrangement of 12q14-15 in Pulmonary Chondroid Hamartoma. Genes Chromosomes Cancer 1993; 8: 131–133
   PubMed Web of Science ®Google Scholar
• Kazmierczak B., Wanschura S., Meyer-Bolte K. Cytogenetic and Molecular Analysis of Aggressive Angiomyxoma. Am. J. Pathol. 1995; 147: 580–585
   PubMed Web of Science ®Google Scholar
• Sreekantaiah C. The Cytogenetic and Molecular Characterization of Benign and Malignant Soft Tissue Tumors. Cytogenet. Cell Genet. 1998; 82: 13–29
   PubMedGoogle Scholar
• Åman P. Fusion Genes in Solid Tumors. Semin. Cancer Biol. 1999; 9: 303–318
   PubMed Web of Science ®Google Scholar
• Bustin M., Reeves R. High Mobility Group Chromosomal Proteins: Architectural Components that Facilitate Chromatin Function. Prog. Nucleic Acid Res. Mol. Biol. 1996; 54: 35–100
   PubMed Web of Science ®Google Scholar
• Hess J.L. Chromosomal Translocations in Benign Tumors: The HMGI Proteins. Am. J. Clin. Pathol. 1998; 109: 251–261
   PubMed Web of Science ®Google Scholar
• Friedmann M., Holth L.T., Zoghbi H.Y., et al. Organization, Inducible-Expression and Chromosome Localization of the Human HMGI(Y) Non-Histone Protein Gene. Nucleic Acids Res. 1993; 21: 4259–4267
   PubMed Web of Science ®Google Scholar
• Manfioletti G., Giancotti V., Bandiera A., et al. cDNA Cloning of the HMGI-C Phosphoprotein, a Nuclear Protein Associated with Neoplastic and Undifferentiated Phenotypes. Nucleic Acids Res. 1991; 19: 6793–6797
   PubMed Web of Science ®Google Scholar
• Patel U.A., Bandiera A., Manfioletti G., et al. Expression and cDNA Cloning of Human HMGI-C Phosphoprotein. Biochem. Biophys. Res. Commun. 1994; 201: 63–70
   PubMed Web of Science ®Google Scholar
• Reeves R., Nissen M.S. The A-T-DNA-Binding Domain of Mammalian High Mobility Group I Chromosomal Proteins: A Novel Peptide Motif for Recognizing DNA Structure. J. Biol. Chem. 1990; 265: 8573–8582
   PubMed Web of Science ®Google Scholar
• Saitoh Y., Laemmli U.K. From the Chromosomal Loops to the Classic Bands of Metaphase Chromosomes. Cold Spring Harbor Symp. Quant. Biol. 1993; 58: 755–765
   PubMedGoogle Scholar
• Saitoh Y., Laemmli U.K. Metaphase Chromosome Structure: Bands Arise from a Differential Folding Path of the Highly AT-Rich Scaffold. Cell 1994; 75: 609–622
   Google Scholar
• Gasser S.M., Laemmli U.K. A Glimpse at Chromosomal Order. Trends Genet. 1987; 3: 16–22
   Web of Science ®Google Scholar
• Moreno S., Nurse P. Substrates for p34cdc2: In Vivo Veritas. Cell 1990; 61: 549–551
   PubMed Web of Science ®Google Scholar
• Reeves R., Langan T.A., Nissen M.S. Phosphorylation of the DNA-Binding Domain of Nonhistone High-Mobility Group I Protein by cdc2 Kinase: Reduction of Binding Affinity. Proc. Natl Acad. Sci. USA 1991; 88: 1671–1675
   PubMed Web of Science ®Google Scholar
• Nissen M.S., Langan T.A., Reeves R. Phosphorylation by cdc2 Kinase Modulates DNA Binding Activity of High Mobility Group I Nonhistone Chromatin Protein. J. Biol. Chem. 1991; 266: 19945–19952
   PubMed Web of Science ®Google Scholar
• Meijer L., Ostvold A.-C., Walaas S.I., et al. High-Mobility-Group Proteins P1, I and Y as Substrates of the M-phase-specific p34cdc2/cyclincdc13 Kinase. Eur. J. Biochem. 1991; 196: 557–567
   PubMedGoogle Scholar
• Reeves R. Chromatin Changes During the Cell Cycle. Curr. Opin. Cell Biol. 1992; 4: 413–423
   PubMedGoogle Scholar
• Thanos D., Maniatis T. The High Mobility Group Protein HMGI(Y) Is Required for NF-κB-Dependent Virus Induction of the Human IFNβ Gene. Cell 1992; 71: 777–789
   PubMed Web of Science ®Google Scholar
• Yie J., Merika M., Munshi N., et al. The Role of HMGI(Y) in the Assembly and Function of the β-Interferon Enhanceosome. EMBO J. 1999; 18: 3074–3089
   PubMed Web of Science ®Google Scholar
• Thanos D., Maniatis T. The High Mobility Group Protein HMI(Y) Is an Essential Structural Component of a Virus Inducible Enhancer Complex. Cold Spring Harbor Symp. Quant. Biol. 1993; 58: 73–81
   PubMedGoogle Scholar
• Thanos D., Maniatis T. Virus Inductionn of Human IFNβ Gene Expression Requires the Assembly of an Enhanceosome. Cell 1995; 83: 1091–1100
   PubMed Web of Science ®Google Scholar
• Munshi N., Merika M., Yie J., et al. Acetylation by HMGI(Y) by CBP Turns off INFβ Expression by Disrupting the Enhanceosome. Mol. Cell 1998; 2: 457–467
   PubMed Web of Science ®Google Scholar
• Abdulkadir S.A., Krishna S., Thanos D., et al. Functional Roles of the Transcription Factor Oct-2A and the High Mobility Group Protein I/Y in HLA-DRA Gene Expression. J. Exp. Med. 1995; 182: 487–500
   PubMed Web of Science ®Google Scholar
• John S., Robbins C.M., Leonard W.J. An IL-2 Response Element in the Human IL-2 Receptor α Chain Is a Composite Element that Binds Stat 5, Elf-1, HMGI(Y), and a GATA Family Protein. EMBO J. 1996; 15: 5627–5635
   PubMed Web of Science ®Google Scholar
• French S.W., Schmidt M.C., Glorioso J.C. Involvement of a High-Mobility Group Protein in the Transcriptional Activity of the Herpes Simplex Virus Latency-Active Promoter 2. Mol. Cell Biol. 1996; 16: 5393–5399
   PubMed Web of Science ®Google Scholar
• Kim J., Reeves R., Rothman P., et al. The Non-histone Chromosomal Protein HMG-I(Y) Contributes to the Immunoglobulin Heavy Chain Germ-Line Epsilon RNA Promoter. Eur. J. Immunol. 1995; 25: 798–808
   PubMed Web of Science ®Google Scholar
• Chuvpilo S., Schomberg C., Gerwig R., et al. Multiple Closely-Linked NFAT/Octamer and HMG-I(Y) Binding Sites are a Part of the Interleukin-4 Promoter. Nucleic Acids Res. 1993; 21: 5694–5704
   PubMed Web of Science ®Google Scholar
• Skalnick D.G., Neufeld E.J. Sequence Specific Binding of HMG-I(Y) to the Proximal Promoters of the GP91-PHOX Gene. Biochem. Biophys. Res. Commun. 1992; 187: 563–569
   PubMed Web of Science ®Google Scholar
• Chase M.B., Haga S.B., Hankins W.D., et al. Binding of HMG-I(Y) Elicits Structural Changes in a Silencer of the Human Beta-Globin Gene. Am. J. Hematol. 1999; 60: 27–35
   PubMed Web of Science ®Google Scholar
• Rommel B., Rogalla P., Jox A., et al. HMGI-C, a Member of the High Mobility Group Family of Proteins, Is Expressed in Hematopoietic Stem Cells and in Leukemia Cells. Leuk. Lymphoma 1997; 26: 603–607
   PubMed Web of Science ®Google Scholar
• Xiang X., Benson K.F., Chada K. Mini-Mouse: Disruption of the Pygmy Locus in a Transgenic Insertional Mutant. Science 1990; 247: 967–969
   PubMed Web of Science ®Google Scholar
• Zhou X., Benson K.F., Ashar H.R., et al. Mutation Responsible for Mouse Pygmy Phenotype in the Developmentally Regulated Factor HMGI-C. Nature 1995; 376: 771–774
   PubMed Web of Science ®Google Scholar
• Johnson K.R., Lehn D.A., Elton T.S., et al. The Chromosomal High Mobility Group Protein HMG-I(Y): Complete Murine cDNA Sequence, and Tissue Expression. J. Biol. Chem. 1988; 263: 18338–18342
   PubMed Web of Science ®Google Scholar
• Johnson K.R., Disney J.E., Wyatt C.R., et al. Expression of mRNAs Encoding Mammalian Chromosomal Proteins HMG-I and HMG-Y During Cellular Proliferation. Exp. Cell Res. 1990; 187: 69–76
   PubMed Web of Science ®Google Scholar
• Lundberg K., Karlson J.R., Ingerigtsen K., et al. On the Presence of the Chromosomal Proteins HMG-I and HMG-Y in Rat Organs. Biochim. Biophys. Acta. 1989; 1009: 277–279
   PubMed Web of Science ®Google Scholar
• Giancotti, V., Buratti, E., Perissin, L., et al. Analysis of HMGI Nuclear Proteins in Mouse Neoplastic Cells Induced by Different Procedures. Exp. Cell Res. 1991, 184, 538–545.
   Google Scholar
• Giancotti, V., Bandiera, A., Burratti, E., et al. Analysis of Multiple Forms of the HMGI Proteins in Rodent and Human Cells: Identification of the Third Protein, HMGI-C in Human Cells. Eur. J. Biochem. 1989, 198, 221–216.
   Google Scholar
• Giancotti V., Bandiera A., Ciani L., et al. High-Mobility-Group-Proteins and Histone H1 Subtypes Expression in Normal and Tumor Tissues of Mouse. Eur. J. Biochem. 1993; 213: 825–832
   PubMedGoogle Scholar
• Giancotti V., Pani B'nra P., Berlingieri M.T., et al. Elevated Levels of a Specific Class of Nuclear Phosphoproteins in Cells Transformed with v-ras and v-mos Oncogenes and by Co-transfection with c-myc and Polyoma Middle T Genes. EMBO J. 1987; 6: 1981–1987
   PubMed Web of Science ®Google Scholar
• Friedman M., Holth L.T., Zoghbi H.Y., et al. Organization, Inducible-Expression and Chromosome Localization of the Human HMG-I(Y) Nonhistone Protein Gene. Nucleic Acids Res. 1993; 21: 4259–4267
   PubMed Web of Science ®Google Scholar
• Lund T., Skålhegg B.S., Holtlund J., et al. Fractionation and Identification of Metaphase-Specific Posphorylated Forms of High-Mobility-Group Proteins. Eur. J. Biochem. 1987; 166: 21–26
   PubMedGoogle Scholar
• Ogram S.A., Reeves R. Differential Regulation of a Multipromoter Gene. J. Biol. Chem. 1995; 270: 14235–14242
   PubMed Web of Science ®Google Scholar
• Johnson K.R., Disney J.E., Wyatt C.R., et al. Expression of mRNAs Encoding Mammalian Chromosomal Proteins HMG-I and HMG-Y During Cellular Proliferation. Exp. Cell Res. 1990; 187: 69–76
   PubMed Web of Science ®Google Scholar
• Bussemakers M.J.G., Van de Ven W.J.M., Debruyne F.M.J., et al. Identification of High Mobility Group Protein I(Y) as Potential Marker for Prostate Cancer by Differential Hybridization Analysis. Cancer Res. 1991; 51: 606–611
   PubMed Web of Science ®Google Scholar
• Tamimi Y., van der Poel H.G., Denyn M.-M., et al. Increased Expression of High Mobility Group Protein I(Y) in High Grade Prostatic Cancer Determined by In Situ Hybridization. Cancer Res. 1993; 53: 5512–5516
   PubMed Web of Science ®Google Scholar
• Ram T.G., Reeves R., Hosick H.L. Elevated High Mobility Group-I(Y) Expression Is Associated with Progressive Transformation of Mouse Mammary Epithelial Cells. Cancer Res. 1993; 53: 2655–2660
   PubMed Web of Science ®Google Scholar
• Berlingieri M.T., Manfioletti G., Santoro M., et al. Inhibition of HMGI-C Protein Synthesis Suppresses Retrovirally Induced Neoplastic Transformation of Rat Thyroid Cells. Mol. Cell Biol. 1995; 15: 1545–1553
   PubMed Web of Science ®Google Scholar
• Schoenmakers E.F.P.M., Geurts J.M.W., Kools P.F.J., et al. A 6-Mb Yeast Artificial Chromosome Contig and Long-Range Physical Map Encompassing the Region on Chromosome 12q15 Frequently Rearranged in a Variety of Benign Solid Tumors. Genomics 1995; 29: 665–678
   PubMed Web of Science ®Google Scholar
• Ashar H.R., Schoenberg Fejzo M., Tkachenko A., et al. Disruption of the Architectural Factor HMGI-C: DNA-Binding AT Hook Motifs Fused in Lipomas to Distinct Transcriptional Regulatory Domains. Cell 1995; 82: 57–65
   PubMed Web of Science ®Google Scholar
• Schoenmakers E.F.P.M., Wanschura S., Mols R., et al. Recurrent Rearrangements in the High Mobility Group Protein Gene, HMGI-C in Benign Mesenchymal Tumors. Nat. Genet. 1995; 10: 436–444
   PubMed Web of Science ®Google Scholar
• Sadler I., Crawford A.W., Michelson J.W., et al. Zyxin and cCRP: Two Interactive LIM Domain Proteins Associated with the Cytoskeleton. J. Cell Biol. 1992; 119: 1573–1587
   PubMed Web of Science ®Google Scholar
• Sánchez-Garcia I., Rabbitts T.H. LIM Domain Proteins in Leukemia and Development. Semin. Cancer Biol. 1993; 4: 349–358
   PubMed Web of Science ®Google Scholar
• Fletcher C.D.M., Akerman M., Dal Cin P., et al. Correlation Between Clinicopathologic Features and Karyotype in Lipomatous Tumors: a Report of 178 Cases from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. Am. J. Pathol. 1996; 148: 623–630
   PubMed Web of Science ®Google Scholar
• Kazmierczak B., Hennig Y., Wanschura S., et al. Description of a Novel Fusion Transcript Between HMGI-C, a Gene Encoding for a Member of the High Mobility Group Proteins, and the Mitochondrial Aldehyde Dehydrogenase Gene. Cancer Res. 1995; 55: 6038–6039
   PubMed Web of Science ®Google Scholar
• Kools P.F., Van de Ven Wim J.M. Amplification of a Rearranged Form of the High Mobility Group Protein Gene HMGIC in OSA-CI Osteosarcoma Cells. Cancer Genet. Cytogenet. 1996; 91: 1–7
   PubMed Web of Science ®Google Scholar
• Fedele M., Serlingieri M.T., Scala S., et al. Truncated and Chimeric HMGI-C Genes Induce Neoplastic Transformation of NIH3T3 Murine Fibroblasts. Oncogene 1998; 17: 413–418
   PubMed Web of Science ®Google Scholar
• Battista S., Fidanza V., Fedele M., et al. The Expression of a Truncated HMGI-C Gene Induces Gigantism Associated with Lipomatosis. Cancer Res. 1999; 59: 4793–4797
   PubMed Web of Science ®Google Scholar
• Schoenberg Fejzo M., Ashar H.R., Krauter K.S., et al. Translocation Breakpoints Upstream of the HMGIC Gene in Uterine Leiomyomata Suggest Dysregulation of this Gene by a Mechanism Different from That in Lipomas. Gene Chromosomes Cancer 1996; 17: 1–6
   PubMed Web of Science ®Google Scholar
• Tallini G., Dal Cin P., Rhoden K.J., et al. Expression of HMGI-C and HMGI(Y) in Ordinary Lipoma and Atypical Limpomatous Tumors: Immunohistochemical Reactivity Correlates with Karyotypic Alterations. Am. J. Pathol. 1997; 151: 37–43
   PubMed Web of Science ®Google Scholar
• Dal Cin P., Wanschura S., Kazmierczak B., et al. Amplification and Expression of the HMGIC Gene in a Benign Endometrial Polyp. Genes Chromosomes Cancer 1998; 22: 95–99
   PubMed Web of Science ®Google Scholar
• Xiao S., Lux M.L., Reeves R., et al. HMG-I(Y) Activation by Chromosome 6p21 Rearrangements in Multilineage Mesenchymal Cells from Pulmonary Hamartoma. Am. J. Pathol. 1997; 150: 901–910
   PubMed Web of Science ®Google Scholar
• Tallini G., Vanni Q., Manfioletti G., et al. HMGI-C and HMGI(Y) Immunoreactivity Correlates with Cytogenetic Abnormalities in Lipomas, Pulmonary Chondroid Hamartomas, Endometrial Polyps and Uterine Leiomyomas and Is Compatible with Rearrangements of the HMGI-C and HMGI(Y) Genes. Lab. Invest. 2000; 80: 359–369
   PubMed Web of Science ®Google Scholar
• Kazmierczak B., Dal Cin P., Wanschura S., et al. HMGIY Is the Target of 6p21.3 Rearrangements in Various Benign Mesenchymal Tumors. Genes Chromosomes Cancer 1998; 23: 279–285
   PubMed Web of Science ®Google Scholar
• Fletcher J.A., Pinkus G.S., Weidner N., et al. Lineage Restricted Clonality in Biphasic Solid Tumors. Am. J. Pathol. 1991; 138: 1199–1207
   PubMed Web of Science ®Google Scholar
• Fletcher J.A., Pinkus G.S., Donovan K., et al. Clonal Rearrangement of Band 6p21 in Mesenchymal Component of Pulmonary Chondroid Hamartoma. Cancer Res. 1992; 52: 6224–6228
   PubMed Web of Science ®Google Scholar
• Fletcher J.A., Pinkus J.L., Lage J.M., et al. Clonal 6p21 Rearrangement Is Restricted to the Mesenchymal Components of an Endometrial Polyp. Genes Chromosomes Cancer 1992; 5: 260–263
   PubMed Web of Science ®Google Scholar
• Kottickal L.V., Sarada B., Ashar H., et al. Preferential Expressiona of HMGI-C Isoforms Lacking the Acidic Carboxyl Terminal in Human Leukemia. Biochem. Biophys. Res. Commun. 1998; 242: 452–456
   PubMed Web of Science ®Google Scholar
• Gu Y., Nakamura T., Alder R., et al. The t(4;11) Translocation of Human Acute Leukemias Fuses the ALL-1 Gene, Related to Drosophila trithorax, to the AF-4 Gene. Cell 1992; 71: 701–708
   PubMed Web of Science ®Google Scholar
• Tkachuk D.C., Kohler S., Cleary M.L. Involvement of a Homolog of Drosophila trithorax by 11q23 Chromosomal Translocations in Acute Leukemias. Cell 1992; 71: 691–700
   PubMed Web of Science ®Google Scholar
• Djabali M., Selleri L., Parry P., et al. A Trithorax-like Gene Is Interrupted by Chromosome 11q23 Translocations in Acute Leukemias. Nat. Genet. 1992; 2: 113–118
   PubMed Web of Science ®Google Scholar
• Domer P.H., Fakharzadeh S.S., Chan C.-S., et al. Acute Mixed Lineage Leukemia t(4;11)(q21;q23) Generates an MLL-AF4 Fusion Product. Proc. Natl Acad. Sci. USA 1993; 90: 7884–7888
   PubMed Web of Science ®Google Scholar
• Zeleznik-Le N.J., Harden A.M., Rowley J.D. 11q23 Translocations Split the “AT-hook” Cruciform DNA-Binding Region and the Transcriptional Repression Domain from the Activation Domain of the Mixed Lineage Leukemia (MLL) Gene. Proc. Natl Acad. Sci. USA 1994; 91: 10610–10614
   PubMed Web of Science ®Google Scholar
• Broeker P.L., Harden A., Rowley J.D., et al. The Mixed Lineage Leukemia Gene (MLL) Protein Involved in 11q23 Translocations Contains a Domain That Binds Cruciform DNA and Scaffold Attachment Region (SAR) DNA. Curr. Top. Microbiol. Immunol. 1996; 211: 259–268
   PubMed Web of Science ®Google Scholar
• Slany R.K., Lavau C., Cleary M.L. The Oncogenic Capacity of HRX-ENL Requires the Transcriptional Transactivation Activity of ENL and the DNA Binding Motifs of HRX. Mol. Cell Biol. 1998; 18: 122–129
   PubMed Web of Science ®Google Scholar
• Kas K., Voz M.L., Roijer E., et al. Promoter Swapping Between the Genes for a Novel Zinc Finger Protein and beta-Catenin in Pleomorphic Adenomas with t(3;8)(p21;q12) Translocations. Nat. Genet. 1997; 15: 170–174
   PubMed Web of Science ®Google Scholar
• Queimado L., Lopes C., Du F., et al. Pleomorphic Adenoma Gene 1 Is Expressed in Cultured Benign and Malignant Salivary Gland Tumor Cells. Lab. Invest. 1999; 79: 583–589
   PubMed Web of Science ®Google Scholar
• Voz M.L., Astrom A.K., Kas K., et al. The Recurrent Translocation t(5:8)(p13;q12) in Pleomorphic Adenomas Results in Upregulation of PLAG1 Gene Expression Under the Control of the LIFR Promoter. Oncogene 1998; 16: 1409–1416
   PubMed Web of Science ®Google Scholar
• Astrom A.K., Voz M.L., Kas K., et al. Conserved Mechanism of PLAG1 Activation in Saliary Gland Tumors with and without Chromosome 8q12 Abnormalities: Identification of SII as a New Fusion Partner Gene. Cancer Res. 1999; 59: 918–923
   PubMed Web of Science ®Google Scholar
• Voz M.L., Agten N.S., Van de Ven W.J., et al. PLAG1, the Main Translocation Partner in Pleomorphic Adenoma of the Salivary Glands, Is a Positive Regulator of IGF-II. Cancer Res. 2000; 60: 106–113
   PubMed Web of Science ®Google Scholar